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Background: Patients with hilar cholangiocarcinoma or hepatolithiasis often develop segmental cho-
langitis (SC), but it is unclear whether hepatectomy for patients with SC can be performed safely.
Methods: Rats were subjected to segmental bile duct ligation (SBDL) with LPS (SC group) or a saline
(Sham group) infusion into the bile duct of the ligated lobes. The rats were sacrificed at 3, 24 and 48 h
after the SBDL. For another experiment, the rats were subjected to partial hepatectomy (PHx) for the
ligated lobes. Hepatic regeneration rates and the expression of regeneration-associated genes were
evaluated.
Results: In the SC group, severe parenchymal damage was observed in the acute phase (3 h). Altered
gene expression in the liver in response to biliary infection occurred not only in the infected lobes but also
in the non-infected lobes. In the rats of the SC group, both the hepatic regeneration rate and serum HGF
levels were significantly lower than in the Sham group.
Conclusion: These results clearly demonstrate that SC impairs the regeneration capacity of the con-
tralateral remnant liver. Therefore, hepatectomy should be avoided for patients with SC even if it occurs
in the part of the liver to be resected.
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Introduction
Patients with cholangiocarcinoma have cholestatic liver injury as a
result of a partial or total obstruction of the bile duct. In the case
of hilar cholangiocarcinoma, the hepatic duct is often partitioned
into several units by the tumour at the hepatic hilum1. Under such
a difficult condition, a segmental biliary infection may develop
and this condition is called segmental cholangitis (SC). A similar
condition is observed in cases of hepatolithiasis which develop in
the branch of the intrahepatic bile duct.2
Several studies have reported that the presence of pre-operative
cholangitis is a major prognostic factor in the outcome of major
hepatic resection for biliary carcinoma.3,4 One clinical study
reported that the presence of SC is a negative prognostic factor for
post-hepatectomy mortality in hilar cholangiocarcinoma.5 The
leading cause of death in the SC group was liver failure.5 However,
these reports are retrospective clinical reviews and there is no
mechanistic study that has evaluated the effects of SC on the
hepatic regeneration capacity after major hepatectomy.
The pathophysiological mechanism of acute obstructive cho-
langitis (AOC) has been studied with several animal models.6,7 In
these models, pro-inflammatory cytokines such as tumour necro-
sis factor-a (TNF-a) and interleukin-6 (IL-6) are believed to be
central to the pathophysiology of organ injury.8 The magnitude
of the increase in these pro-inflammatory cytokines strongly
correlates with severity of multiple organ failure and mortality.9
Furthermore, it has been shown in animal septic models that the
presence of systemic infection delays liver regeneration.10,11
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However, whether SC affects the hepatic regeneration capacity
after hepatectomy is unknown.
After hepatectomy, several growth factors are reported to play a
crucial role in the regulation of regeneration by providing either
stimulatory or inhibitory signals to hepatocytes. Hepatocyte
growth factor (HGF) and epidermal growth factor (EGF) stimu-
late DNA synthesis in hepatocytes in vivo and in culture, and are
known to be the most powerful mitogens of hepatocytes.12 In the
liver, HGF is produced by non-parenchymal cells, mainly by
hepatic stellate cells (HSCs).13,14 However, in the injured liver,
HSCs are activated and lose HGF productivity.12,13 On the other
hand, transforming growth factor-b1 (TGF-b1), which is
produced by activated HSCs, is a potent growth inhibitor
of hepatocytes.15–17 However, it is not clear how these liver
regeneration-associated factors are modulated under the con-
dition of SC.
In the present study, a rat SC model induced by segmental bile
duct ligation (SBDL) and lipopolysaccharide (LPS) infusion into
the ligated bile duct was established. The regeneration capacity
of the liver after partial hepatectomy was evaluated by resecting
the lobes subjected to SBDL.
Materials and methods
Materials
All chemicals were purchased from Sigma Chemical Co. (St Louis,
MO, USA).
Animals
Male Wister rats (250–300 g) were purchased from SLC (Tokyo,
Japan). The animals were kept in a temperature- and humidity-
controlled environment in a 12-h light/dark cycle. Animals were
allowed free access to water and food at all times. All experiments
were approved by the Regulations for Animal Experiments in
Nagoya University.
Experiment 1 (SC-Induction)
The rats were randomly assigned to one of two groups: the Sham
group and the Segmental cholangitis (SC) group. In both groups,
all surgical procedures were performed under general anaesthesia
by inhalation of the diethyl ether. The abdomen was opened with
a median incision. A PE-10 polyethylene catheter (Imamura Co.,
Tokyo, Japan) was placed and tied with 5–0 silk thread in the bile
duct of the left lateral and median lobes (= left hepatic duct),
which are equivalent to 70% of the liver (Fig. 1a). A micro syringe
was connected to the catheter, and 0.15 ml of saline (for the Sham
group) or LPS (purified from Escherichia coli O111:B4; 1 mg/ml)
(for the SC group) was slowly injected into the bile duct. The
volume of fluid infused into the bile duct was determined based
on a previous study showing that infusion of 0.15 ml of contrast
material does not cause parenchymography.18 Afterwards, the left
hepatic duct was ligated just above the tip of the PE-10 polye-
thylene catheter. Then, the PE-10 polyethylene catheter was
removed and the left hepatic duct was transected between the
ligatures. The rats were sacrificed at 3, 24, and 48 h after the
segmental bile duct ligation (SBDL, n = 8 at each time point) and
blood samples were obtained. The liver tissues were separately
harvested from the lobes with or without the SBDL.
Experiment 2 (Hepatectomy after SC-Induction)
For experiment 2, the rats were subjected to 70% partial hepate-
ctomy (PHx) at 3, 24 and 48 h after the induction of SC. Briefly,
a median incision was made and the liver was freed from its
ligaments. The left lateral and median lobes (equivalent to 70% of
the liver, the lobes subjected to the SBDL) were ligated with 4–0
silk sutures and resected. The rats were sacrificed on day 1 and 7
after the PHx (n = 8 at each time point) and blood and liver tissues
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Figure 1 (a) Schema showing the segmental bile duct ligation
(SBDL) procedure and the injection of saline or lipopolysaccharide
(LPS) (concentration; 1 mg/ml) into the bile duct. (b) Schedules
of experiment 1 (SC-Induction) and 2 (Hepatectomy after
SC-Induction)
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from the remnant lobes were harvested at each time point.
Schedules for all procedures are shown in Fig. 1b.
Biochemical assays for blood sample
Serum levels of aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) were measured using standard laboratory
methods.
Determination of hepatic mRNA expression by
real-time RT-PCR
To measure changes in gene expression related to liver regenera-
tion, quantitative real time reverse transcription-polymerase
chain reaction (RT-PCR) analysis was performed with an Applied
Biosystems Prism 7300 sequence detection system (Applied Bio-
systems Inc., Foster City, CA). Four different liver samples were
harvested at each time point (3, 24 and 48 h after the SBDL): (i)
samples from the non-SBDL lobes in the Sham group; (ii) samples
from the non-SBDL lobes in the SC group; (iii) samples from the
SBDL lobes in the Sham group; and (iv) samples from the SBDL
lobes in the SC group. Total RNA was isolated from liver tissues
using a Qiagen RNeasy mini kit (Qiagen, GmbH, Germany)
according to the manufacturer’s protocol. The cDNA was gener-
ated from the total RNA samples using a SuperScript III reverse
transcriptase reagent (Invitrogen, Carlsberg, CA, USA). Each
reaction was performed in a 20-ml reaction mixture containing
cDNA, each probe and primer set, and a 2¥ PCR Master Mix
(Applied Biosystems, Foster City, CA, USA). TaqMan gene expres-
sion assays (Applied Biosystems) for interleukin-6 (IL-6), tumor
necrosis factor-a (TNF-a), inducible nitric oxide synthase
(iNOS), nuclear factor-kB (NF-kB), hepatocyte growth factor
(HGF), epidermal growth factor (EGF), transforming growth
factor-b1 (TGF-b1), interleukin-1b (IL-1b), a-smooth muscle
actin (a-SMA) and 18S rRNA (endogenous control) were
purchased as a probe and primer set (IL-6, Rn00561420_m1;
TNF-a, Rn01525860_g1; iNOS, Rn00561646_m1; NF-kB,
Rn01399583_m1; HGF, Rn00566673_m1; EGF, Rn00563336_m1;
TGF-b1, Rn99999016_m1; IL-1b, Rn00580432_m1; a-SMA,
Rn01759928_g1; and 18S rRNA, Hs99999901_s1). The reaction
mixture was denatured with one cycle of 10 min at 95°C and
incubated for 40 cycles (denaturing for 15 s at 95°C and annealing
and extending for 1 min at 60°C). The amplification data were
analysed with Applied Biosystems Prism sequence detection soft-
ware (Applied Biosystems, version 2.1). In each experiment, the
relative expression of the gene of interest was normalized to the
18S control using standard curves prepared for each gene and
average values were used for quantification. The average of liver
samples from the non-SBDL lobes in the Sham group was set as
one-fold induction, and other data were adjusted to that baseline.
Evalualtion of hepatic regeneration after PHx
The restitution of the liver weight was determined as the percent-
age of regenerated liver mass and calculated by the following
equation as described before: hepatic regeneration rate (%) = 100
¥ [C - (A - B)]/A; in which A is the estimated total liver weight at
the time of the partial hepatectomy, B is the excised liver weight
and C is the weight of the regenerated liver at the final resection.19
The mitotic index was determined in paraffin-embedded liver
samples stained with haematoxylin and eosin. The mitotic index
was expressed as the percentage of mitotic hepatocytes per the
total number of hepatocytes in high-power fields (HPF).19 Six
fields from one specimen were evaluated for eight animals in
each group.
Enzyme-linked immunosorbent assay (ELISA) for
hepatic regeneration-associated factors after PHx
HGF is well known as the most powerful mitogen for the hepa-
tocytes. On the other hand, IL-1b is known as a strong inhibitor of
liver regeneration.20 Therefore, serum HGF and IL-1b levels were
determined at 3, 24 and 48 h after the SBDL and on day 1 after the
PHx using a commercially available sandwich enzyme-linked
immunosorbent assay (ELISA) kit (HGF; Institution of Immu-
nology, Tokyo, Japan: IL-1b; R&D Systems, Minneapolis, MN,
USA) according to the manufacturer’s protocol.
Immunohistochemistry for a-smooth muscle
actin (a-SMA)
To detect the expression of a-SMA, the automated slide prepara-
tion systemDiscovery XT (VentanaMedical Systems, Inc., Tucson,
AZ) was used. Before staining, paraffin sections were heated at
65°C for 30 min in a paraffin oven and were blocked with 1%
non-fat milk. The staining procedure was carried out according to
the manufacturer’s protocol (Ventana Medical Systems, Inc.).
Anti-a-SMA antibody (Dako, Glostrup, Denmark) was diluted in
Discovery® Ab diluent (Ventana Medical Systems, Inc.).
Statistical analysis
There were six to eight animals in each group. The results are
presented as the mean standard error (SE). The Student’s t-test
was used to compare the Sham and the SC group. The survival
data were analysed by Kaplan–Meier survival analysis with log
rank test using SPSSII (SPSS Japan Inc, Tokyo, Japan). A P-value
of less than 0.05 was considered to indicate significant difference.
Results
Experiment 1 (SC-Induction)
Serum parameters for liver function
The total serum AST and ALT levels in the SC group were signifi-
cantly higher compared with those in the Sham group in only the
acute phase (3 h) after the SBDL (Fig. 2). However, in the late
phase (24 and 48 h) these levels in the SC group were not different
from those in the Sham group (Fig. 2). These results indicate that
our SC model induces severe parenchymal damage in the acute
phase (3 h) and the damage is quickly recovered in the late phase
(24 and 48 h).
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Real-time RT-PCR for inflammation- and liver
regeneration-associated factors after SBDL
Both in the SBDL and non-SBDL lobes, the gene expression of
inflammation-associated factors at 3, 24, and 48 h after the SBDL
were examined using real-time RT-PCR.At 3 h after the SBDL, the
expression of IL-6, TNF-a, iNOS and NF-kB mRNA in the SBDL
lobes was markedly increased in the SC group compared with
in the Sham group (Fig. 3). However, this difference disappeared
at 24 and 48 h after the SBDL. Interestingly, a similar trend was
observed in the non-SBDL lobes, in which the liver tissue was not
directly exposed to LPS.
These results strongly imply that in the SC model, altered
gene expression in the infected lobes (= the SBDL lobes) parallels
that in the non-infected lobes (= the non-SBDL lobes). In a
previous clinical review, it was shown that the presence of
pre-operative intra-hepatic SC was a major prognostic factor for
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Figure 2 Serum aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) levels at 3, 24 and 48 h after the segmental
bile duct ligation (SBDL). Blood samples were obtained from the
abdominal aorta. Data are means  SE of eight animals in each
group. *P < 0.05 vs. Sham by t-test
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Figure 3 The gene expression of inflammation-associated factors
(IL-6, TNF-a, iNOS, and NF-kB) in the livers from both the segmental
bile duct ligation (SBDL) lobes and the non-SBDL lobes at 3, 24, and
48 h after the SBDL. Liver samples were harvested at each time
point (3, 24 and 48 h) from both the non-SBDL lobes and the SBDL
lobes. The average expression level of the non-SBDL lobes in the
Sham group at each time point was set to 1.0, and other data were
adjusted to this baseline. Data are means  SE of eight animals in
each group. *P < 0.05 vs. Sham by t-test. IL-6, interleukin-6; TNF-a,
tumour necrosis factor-a; iNOS, inducible nitric oxide synthase;
NF-kB, nuclear factor-kB
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post-hepatectomy mortality.5 However, it is still unclear whether
the resection of the liver lobes can be safely performed after the
attack of segmental cholangitis. Thus, in the next series of experi-
ment, the remnant liver function after resecting the SBDL lobes
was examined.
Experiment 2 (Hepatectomy after SC-induction)
Serum parameters for hepatic function
At 3, 24 and 48 h after the SBDL, the rats were subjected to 70%
PHx of the SBDL lobes. These rats were sacrificed on day 1 and 7
after the PHx (n = 8 at each time point) and blood and liver tissue
obtained from the remnant lobes were harvested at each time
point. The serum AST and ALT levels in the SC group on day 1
after the PHx were significantly higher than those in the Sham
group (Fig. 4). These results indicate that there is more severe
hepatic damage after PHx in the SC group compared with in the
Sham group.
Hepatic regeneration rate after PHx
The percentage of newly regenerated liver weight (hepatic regen-
eration rate) was examined on day 1 and 7 after the PHx. On day
1 after the PHx, the hepatic regeneration rate of the rats in the
SC group at 3 h after the SBDL was significantly lower than that in
the Sham group, although there was no significant difference
between the Sham and the SC group at 24 and 48 h after the SBDL
(Fig. 5a). Furthermore, the mortality rate of the rats in the SC
group at 3 h after the SBDL was 75% and was significantly higher
than in the Sham group (mortality rate; 0%) (Fig. 5b). These
results indicate that in the acute phase (3 h) of segmental cholan-
gitis, the liver was placed under severe stress and the onset of
hepatic regeneration delayed. Injection of LPS into the peritoneal
cavity, with the same dose used for segmental cholangitis, neither
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Figure 4 Serum aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) levels on day 1 after partial hepatectomy
(PHx) which was performed at 3, 24 and 48 h after the segmental
bile duct ligation (SBDL). Data are means  SE of eight animals in
each group. *P < 0.05 vs. Sham by t-test
Sham
SC
Liver regeneration rate
20
15
10
5
0
3 h 24 h 48 h
∗
%
A
B
Sham
SC
Survival rate after PHx
(PHx was performed at 3 h after SBDL)
100
80
60
40
20
0
S
ur
vi
va
l r
at
e 
%
100%
∗ 25%
0 1 2 3 4 5 6 7
days
Figure 5 (a) Percentage of the newly regenerated liver weight
(hepatic regeneration rate) on day 1 after the partial hepatectomy
(PHx), which was performed at 3, 24 and 48 h after the segmental
bile duct ligation (SBDL). Data are means  SE of eight animals in
each group. *P < 0.05 vs. Sham by t-test. (b) Survival rate of rats
after the PHx, which was performed at 3 h after the SBDL. Statistical
difference between the groups was determined by Kaplan–Meier
survival analysis. *P < 0.05 vs. Sham
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Figure 6 (a) Mitotic index evaluated by histological examination on day 1 after the partial hepatectomy (PHx), which was performed at 3, 24
and 48 h after the segmental bile duct ligation (SBDL). Data are means  SE of eight animals in each group. *P < 0.05 vs. Sham by t-test.
(b) Representative micrographs of the remnant liver on day 1 after the PHx, which was performed at 3 h after the SBDL (haematoxylin and
eosin staining). Arrows indicate the hepatocytes with mitosis (original magnification ¥ 200). (c) The gene expression of hepatic regeneration-
associated factors (hepatic regeneration promoters, HGF and EGF; hepatic regeneration inhibitors, TGF-b and IL-1b) in the liver of the
remnant lobes on day 1 after the PHx, which was performed at 3 h after the SBDL. The average expression level of the Sham group's data
at each time point was set to 1.0, and other data were adjusted to this baseline. Data are means  SE of eight animals in each group.
*P < 0.05 vs. Sham by t-test. HGF, hepatocyte growth factor; EGF, epidermal growth factor; TGF-b, transforming growth factor-b; IL-1b,
interleukin-1b
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induced an impaired hepatic regeneration rate nor lead to mor-
tality, indicating that pathophysiology of SC is different from that
of systemic infection (data not shown).
Mitotic index of the regenerated liver after PHx
The mitotic index in the regenerating liver was also examined
on day 1 after the PHx. The mitotic index in the SC group at 3 h
after the SBDL was significantly lower than in the Sham group
(Fig. 6a–b). These results also imply the delayed onset of hepatic
regeneration in the SC rats in the acute phase.
Real-time RT-PCR for hepatic regeneration-associated
factors after PHx
In the next experiment, the activation of hepatic regeneration-
associated factors in the remnant liver was examined on day 1 after
the PHx, which was performed at 3 h after the SBDL. The expres-
sion of mRNA for hepatic regeneration promoters such as HGF
and EGF in the SC group was significantly lower than in the
Sham group (Fig. 6c). In contrast, the expression of mRNA for
hepatic regeneration inhibitors such as TGF-b1 and IL-1b in the
SC group was significantly higher than in the Sham group
(Fig. 6c). These results also imply that the presence of SC in the
SBDL lobes impairs the regeneration potential of the remnant
liver (= non-SBDL lobes).
ELISA for hepatic regeneration-associated factors
after PHx
Serum levels of HGF (a promoter of liver regeneration) and IL-1b
(an inhibitor of liver regeneration) before the PHx and day 1 after
the PHx were examined. Serum HGF levels at 3 h after SBDL in
the SC group were significantly lower than in the Sham group
(Fig. 7). In sharp contrast, serum IL-1b levels in the SC group
were significantly higher than in the Sham group (Fig. 7). These
results further indicate that SC suppresses the production of
hepato-proliferative factors and increases the production of
inhibitors of liver regeneration.
Immunohistochemistry and real-time RT-PCR for
a-smooth muscle actin (a-SMA)
According to these results, the SC in the SBDL lobes significantly
inhibited the production of HGF even in the non-SBDL lobes.
However, it is unclear through which mechanism, the production
of HGF declined. In the injured liver, non-activated HSCs change
to activated HSCs. Under such conditions, HSCs produce more
a-smooth muscle actin (a-SMA) and the productivity of HGF is
attenuated.12 HSCs are known to be located in the space of Disse,
below the sinusoidal endothelial cells lining.21 Therefore, in the
next experiment, the expression of a-SMA in both the SBDL and
non-SBDL lobes at 3 h after the SBDL and real-time RT-PCR were
examined using immunohistochemistry. At 3 h after the SBDL,
the expression of a-SMA around the sinusoid was markedly
increased in the SC group compared with that in the Sham group
both in the SBDL and non-SBDL lobes (Fig. 8a). Furthermore, a
similar trend was observed by real-time RT-PCR for a-SMA
(Fig. 8b). These results further indicate that SC activates HSCs
even in the contralateral liver segment and decreases the pro-
ductivity of HGF in these cells.
Discussion
Patients with hilar cholangiocarcinoma or hepatolithiasis occa-
sionally develop SC as a result of partial obstruction of the biliary
branch and bacterial contamination. However, it is necessary to
perform major hepatectomy and caudate lobectomy with biliary
resection for these diseases. In such case, whether SC becomes a
negative prognostic factor for major hepatectomy is questionable,
because there is no well-controlled clinical study that has
evaluated the safety of major hepatectomy for patients with SC.
Moreover, no information is available on the hepatic regenera-
tion capacity in patients with SC after major hepatectomy. In this
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Figure 7 Serum hepatocyte growth factor (HGF) and interleukin-1b
(IL-1b) levels at 3 h after the segmental bile duct ligation (SBDL)
(before PHx) and on day 1 after the partial hepatectomy (PHx) which
was performed at 3 h after the SBDL. Blood samples were obtained
from the abdominal aorta. Serum levels of HGF and IL-1b were
determined using an enzyme-linked immunosorbent assay (ELISA).
Data are means  SE of eight animals in each group. * P < 0.05 vs.
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regard, the results of the present study first of all have estab-
lished and characterized a rat SC model and thus provide useful
information.
In the present study, it was demonstrated that in the rats with
SC, especially in the acute phase, biochemical assays of liver injury
were significantly higher than in the Sham group. Furthermore, in
the SC group, the expression of liver regeneration-inhibiting genes
was significantly higher than in the Sham group especially in the
acute phase (3 h after SBDL). For another experiment, PHx was
performed. In the SC group in the acute phase, the regeneration
rate after the PHx was significantly lower than in the Sham group.
Moreover, the mortality rate was significantly higher in the SC
group than in the Sham group. Interestingly, these effects were not
observed when LPS was injected into the peritoneal cavity, indi-
cating that the pathophysiology of SC is different from systemic
infection. These results also indicate that SC can be a deteriorating
factor for liver regeneration and can be a strong negative prog-
nostic factor for major hepatectomy.
It is widely known that endotoxin activates hepatic stellate
cells (HSCs)22 and then activated HSCs (identified by positive
staining for a-SMA) produce TGF-b1, a potent growth inhibitor
of hepatocytes.23,24 Additionally, the activated HSCs have been
shown to lose ability to produce HGF,13,25 a major liver regenera-
tion promoting factor. There are other liver regeneration regulat-
ing factors including EGF as a liver regeneration promoting
factor and IL-1b20 as liver regeneration inhibiting factors. In
the present study, we found a significantly lower expression of
liver regeneration-promoting genes (HGF and EGF mRNA) and a
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Figure 8 (a) Immunohistochemistry fora-smooth muscle actin (a-SMA) protein in the liver at 3 h after the segmental bile duct ligation (SBDL)
(original magnification ¥ 400). (b) The gene expression of a-SMA in the livers from both the SBDL lobes and the non-SBDL lobes 3 h after
the SBDL. The average expression level of the non-SBDL lobes in the Sham group at each time point was set to 1.0, and other data were
adjusted to this baseline. Data are means  SE of eight animals in each group. *P < 0.05 vs. Sham by t-test
HPB 671
HPB 2010, 12, 664–673 © 2010 International Hepato-Pancreato-Biliary Association
significantly higher expression of liver regeneration-suppressing
genes (TGF-b1 and IL-1b mRNA) in the liver in the SC group
than in the Sham group.Moreover, significantly lower serumHGF
levels and significantly higher serum IL-1b levels in the SC group
than in the Sham group were also observed. Taken together, it is
evident that SC, even if it occurs only in the SBDL lobes and those
lobes are removed by the partial hepatectomy, impairs the overall
regenerating capacity of the remnant liver (the non-SBDL lobes).
It could be speculated that this change is what led to a significantly
higher mortality rate after partial hepatectomy in the SC group
as compared with the Sham group. One of the triggers of the
deteriorated liver regeneration in the SC group may be the acti-
vation of HSCs; this theory was indirectly confirmed by increased
expression of a-SMA around the sinusoidal lining.
Although it was unable to determine the mechanism by which
SC not only influences the infected lobes but also influences the
non-infected lobes, it is not conceivable that LPS infused into the
bile duct is directly drained into the systemic circulation as the
volume of infusion is very low. Therefore, our SC model is differ-
ent from that with systemic LPS administration. An inflammatory
response of acute obstructive cholangitis can be a major cause
of systemic inflammatory response syndrome (SIRS).26,27 In the
opposite direction, SIRS from various diseases such as acute
pancreatitis, urinary tract infection and peritonitis results in liver
failure.28 Therefore, it is conceivable that the infected lobes
induced by SC began to release mediators that affect the function
of the non-infected lobes. The precise mechanism should be
elucidated in future studies.
It could be argued that the infusion of LPS instead of bacteria
into the bile duct might fail to fully reproduce clinical cholangitis.
While Escherichia coli is the most frequent biliary pathogen
isolated in patients with acute cholangitis in both western and
eastern countries.29,30 However, other species such as Klebsiella
(another Gram-negative rod) are also commonly isolated in
patients with acute cholangitis.31 Furthermore, in many animal
sepsis models, the LPS models show trends similar to those in
models using Escherichia coli.32,33 Therefore, in this study, LPS (a
common pathogen found in both Escherichia coli and Klebsiella)
was used as a representative antigen responsible for cholangitis.
In summary, the present study clearly demonstrated that seg-
mental cholangitis, especially in the acute phase (3 h), impairs the
hepatic regeneration capacity of the remnant liver after partial
hepatectomy. Therefore, hepatectomy should be avoided in
patients with acute SC even if it occurs on the side of the liver
resection.
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